Novyra Pharmachem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 26, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	68	93	37	21	60	29
Market Cap Growth	105.77%	154.16%	76.35%	-65.57%	107.71%	-12.07%
Enterprise Value	66	90	35	20	59	28
Last Close Price	10.70	14.97	5.89	3.34	9.70	4.67
PE Ratio	-	-	-	-	519.54	855.13
PS Ratio	64.88	88.87	-	-	40.08	19.30
PB Ratio	10.89	14.91	0.61	0.35	0.99	0.48
P/OCF Ratio	-	-	-	-	43.50	-
EV/Sales Ratio	63.18	86.32	-	-	39.60	18.79
EV/EBITDA Ratio	-	-	-	-	131.88	-
EV/EBIT Ratio	-	-	-	-	227.84	-
Net Debt / Equity Ratio	-0.28	-0.28	-0.04	-0.01	-0.04	-0.01
Net Debt / EBITDA Ratio	0.03	0.03	8.75	0.61	-4.92	4.99
Asset Turnover	0.03	0.03	-	-	0.02	0.02
Quick Ratio	0.22	0.22	1.81	2.44	6.55	3.87
Current Ratio	0.86	0.86	1.81	2.51	6.66	4.36
Return on Equity (ROE)	-162.40%	-162.40%	-1.07%	-2.65%	0.19%	0.06%
Return on Assets (ROA)	-87.66%	-87.66%	-0.65%	-1.61%	0.26%	-0.36%
Return on Invested Capital (ROIC)	-163.30%	-162.40%	-1.06%	-2.65%	0.15%	-0.49%
Earnings Yield	-79.34%	-57.92%	-1.74%	-7.70%	0.19%	0.12%
Buyback Yield / Dilution	-	-	-2.14%	-	-	-